TERF1

Across TCGA pan-cancer cohorts, TERF1 mass-spec protein differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of TERF1’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where TERF1 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types TERF1 is over-expressed in tumor, although a few such as PDAC and CCRCC show the opposite, repressed pattern.

PDAC, CCRCC, and LUAD are the cancer types where TERF1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TERF1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PDAC	Male	II,III,IV	−0.631	<.001	7	view →
CCRCC	All	All	−0.298	<.001	5	view →
LUAD	All	II,III,IV	−0.123	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

TERF1–PDAC

Open the PDAC breakdown →